Active Clinical Research: Pancreatic Cancer

Comprehensive Cancer Centers is running the following clinical research studies for pancreatic cancer.

A Phase 3 Multicenter, Open-label, Randomized, 2 Arm Study of Adjuvant Daraxonrasib versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma (PDAC).
Study#: Pending
Contact Us: For information about this clinical study, Email Us.